Investigative Urology - Results from #5760

Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: Functional differences between sphingosine kinase 1a and 1b - Abstract August 21, 2012

Cyclosporin A suppresses prostate cancer cell growth through CaMKKβ/AMPK-mediated inhibition of mTORC1 signaling - Abstract August 20, 2012

DNMT1: An emerging target in the treatment of invasive urinary bladder cancer - Abstract August 20, 2012

Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer - Abstract August 20, 2012

Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells - Abstract August 20, 2012

Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy - Abstract August 20, 2012

The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell lines - Abstract August 20, 2012

Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer models - Abstract August 17, 2012

Suggestive evidence of linkage identified at chromosomes 12q24 and 2p16 in African American prostate cancer families from Louisiana - Abstract August 17, 2012

Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1 - Abstract August 17, 2012

No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients - Abstract August 17, 2012

Spondin-2 (SPON2), a more prostate-cancer-specific diagnostic biomarker - Abstract August 17, 2012

Epigenetic markers of prostate cancer in plasma circulating DNA - Abstract August 17, 2012

Vascular responses to radiotherapy and androgendeprivation therapy in experimental prostate cancer - Abstract August 17, 2012

Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation - Abstract August 16, 2012

αB-Crystallin in clear cell renal cell carcinoma: Tumor progression and prognostic significance - Abstract August 16, 2012

CD10(+) and CK7/RON(-) immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers - Abstract August 16, 2012

Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo - Abstract August 16, 2012

MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples - Abstract August 16, 2012

Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer - Abstract August 16, 2012

Page 289 of 346